Company intelligence / Profile preview

Future Ventures

San Francisco, California, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Future Ventures is an active early-stage venture capital firm with a strong funding record in disruptive life sciences and biotech startups—including those pioneering gene therapy manufacturing, synthetic biology, and AI-enabled drug discovery—with several portfolio companies reaching IPOs or large acquisitions.

Therapeutic areas: Other
Modalities: Synthetic biologyGene therapy manufacturingMedical therapeuticsmRNA-based drugsSmall molecule
Industry: Investors

Partnerships

SpaceXTeslaNeuralink (Musk companies)Memphis Meats (now Upside Foods)64x BioGameto

Beyond the preview

Go deeper on Future Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Future Ventures.

Explore the full profile